Central Nervous System Cancers Clinical Practice Guidelines in Oncology

作者：Nabors Louis Burt^*; Ammirati Mario; Bierman Philip J; Brem Henry; Butowski Nicholas; Chamberlain Marc C; DeAngelis Lisa M; Fenstermaker Robert A; Friedman Allan; Gilbert Mark R; Hesser Deneen; Holdhoff Matthias; Junck Larry; Lawson Ronald; Loeffler Jay S; Maor Moshe H; Moots Paul L; Morrison Tara; Mrugala Maciej M; Newton Herbert B; Portnow Jana; Raizer Jeffrey J; Recht Lawrence; Shrieve Dennis C; Sills Allen K; Tran David; Tran Nam; Vrionis Frank D

来源：Journal of the National Comprehensive Cancer Network, 2013, 11(9): 1114-1151.

DOI：10.6004/jnccn.2013.0132

Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemotherapy and radiation as the new standard for treating patients with pure or mixed anaplastic oligodendroglioma harboring the 1p/19q codeletion. For metastatic disease, increasing evidence supports the efficacy of stereotactic radiosurgery in treating patients with multiple metastatic lesions but low overall tumor volume. These guidelines provide recommendations on the diagnosis and management of this group of diseases based on clinical evidence and panel consensus. This version includes expert advice on the management of low-grade infiltrative astrocytomas, oligodendrogliomas, anaplastic gliomas, glioblastomas, medulloblastomas, supratentorial primitive neuroectodermal tumors, and brain metastases. The full online version, available at NCCN. org, contains recommendations on additional subtypes.

• 出版日期2013-9
• 单位西北大学